Plenary Session

3.73 CheckMate 577: Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

05.12.2021 - By Vinay Prasad, MD MPHPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

On today's episode, we have a short monologue for you on the recent CheckMate 577 study that was recently published in the New England Journal of Medicine. The title of the paper is "Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer".

CheckMate 577: doi.org/10.1056/NEJMoa2032125

Back us on Patreon! www.patreon.com/plenarysession

Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

More episodes from Plenary Session